Canada’s review of Pfizer-BioNTech’s COVID-19 vaccine for children between the ages of 5 to 11 should be completed within the next “one to two weeks,” Health Canada’s chief medical adviser said today.
from CBC | Health News https://ift.tt/30sSaIp
Canada’s review of Pfizer-BioNTech’s COVID-19 vaccine for children between the ages of 5 to 11 should be completed within the next “one to two weeks,” Health Canada’s chief medical adviser said today.
Aucun commentaire:
Enregistrer un commentaire